Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Placebo-controlled, Long-term Study of Depigoid Birch 5000 in Adults and Adolescents With Allergic Rhinitis and/or Rhinoconjunctivitis With or Without Intermittent Asthma

NCT01694836 is registered in ClinicalTrials.gov with Leti Pharma GmbH as lead sponsor.

NCT NCT01694836
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01694836 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Placebo-controlled, Long-term Study of Depigoid Birch 5000 in Adults and Adolescents With Allergic Rhinitis and/or Rhinoconjunctivitis With or Without Intermittent Asthma
Lead sponsor
Leti Pharma GmbH
Phase
Phase 3
Overall status
Completed
Start date
September 17, 2012
Completion date
July 30, 2018
Enrollment
634 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

allergic rhinitis/rhinoconjunctivitis +-intermittent asthma, sensitization against betula alba (birch) pollen